MétaCan
Menu
Back to cohort
Record W7117450076 · doi:10.1017/s0266462325101487

PD11 First Comprehensive Assessment Of Artificial Intelligence At Canada’s Drug Agency: Evidence Review Methods, Lessons Learned, And Next Steps

2025· article· en· W7117450076 on OpenAlexaboutno aff
Calvin Young, Chantelle C. Lachance, Allison Gates, Ana Komparic, Angie Hamson, Bernice Tsoi, Caitlyn Ford, Renata Axler, Joanne Kim, Chris Kamel, Laura Weeks

Bibliographic record

VenueInternational Journal of Technology Assessment in Health Care · 2025
Typearticle
Languageen
FieldMedicine
TopicArtificial Intelligence in Healthcare and Education
Canadian institutionsnot available
Fundersnot available
KeywordsHealth technologyMedical diagnosisMEDLINEDigital healthAgency (philosophy)Health information technologyEquity (law)Clinical decision support system

Abstract

fetched live from OpenAlex

Introduction Canada’s Drug Agency (CDA-AMC) conducted a health technology assessment of RapidAI for detecting ischemic stroke and hemorrhagic stroke to test and learn from its first comprehensive assessment of an artificial intelligence (AI)-enabled health technology. Methods The assessment included a review evaluating the effectiveness, accuracy, and cost-effectiveness of RapidAI for detecting ischemic and hemorrhagic stroke, alongside an implementation review capturing digital infrastructure considerations. Ethics and equity considerations were integrated throughout, informed by literature, patient engagement, and expert input. Checklists and other AI or digital health tools were applied. The Health Technology Expert Review Panel (HTERP), an advisory body to CDA-AMC, reviewed the evidence and developed recommendations on the appropriate use of RapidAI for stroke detection, considering the following domains: unmet clinical need, clinical value, economic considerations, impacts on health systems, and distinct social and ethical considerations. Results Patient input highlighted speed and accuracy in stroke diagnosis. Low certainty clinical evidence suggested that using the AI functionalities of RapidAI to assist diagnoses may result in clinically important time reductions. Its effects on other clinical outcomes were very uncertain. Ethical and equity considerations have implications across the technology life cycle when using RapidAI for detecting stroke; however, little relevant information was identified from the literature. We found no relevant economic evaluations. The implementation review identified key considerations for AI-enabled health technologies for decision-makers. Given the evidence gaps and uncertainty, HTERP could not recommend for or against the use of RapidAI for stroke detection. Conclusions Our appraisal and deliberative processes identified evidence limitations that may be common across many AI-enabled health technologies, identifying challenges that need to be addressed in their evaluation. Based on this experience, for AI evaluations CDA-AMC plans to add AI-specific implementation and other considerations to its evidence reviews and to consider a broader range of information sources.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.091
metaresearch head score (Gemma)0.247
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Evaluation · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.922
Threshold uncertainty score0.951

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0910.247
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0050.008
Bibliometrics0.0210.017
Science and technology studies0.0030.003
Scholarly communication0.0150.006
Open science0.0060.006
Research integrity0.0070.007
Insufficient payload (model declined to judge)0.0180.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.228
GPT teacher head0.569
Teacher spread0.340 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designSystematic review
DomainEvaluation
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueInternational Journal of Technology Assessment in Health CareSame topicArtificial Intelligence in Healthcare and EducationFrench-language works237,207